[ET Net News Agency, 8 July 2024] IMMUNEONCO-B (01541) rose 12.7% to HK$13.86, breaking
above the 10-D SMA of HK$13.478.
It hits an intra-day high of HK$13.86, and an intra-day low of HK$12.12, hitting a
historical low. The total shares traded was 153,200, with a value of HK$1.9m. The active
buy/sell ratio is 99:1, with net buying turnover of HK$1.65m. FUTU SEC INT'L accounts for
greatest net responsive selling turnover of HK$768,148, with volume weighted average price
of HK$12.35.
Basic Information
=================
-----------------------------------
Nominal 13.860 % Chg +12.68%
High 13.860 Low 12.120
Shares Tr 153,200 Turnover 1.9m
10-D SMA 13.478 %H.V 41.632
20-D SMA 14.006 VWAP 12.394
50-D SMA 14.380 RSI14 48.972
-----------------------------------
Status: Breaking above the 10-D SMA, hitting a historical low, active buy/sell ratio is
99:1, with net buying turnover of HK$1.65m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 13.86 +12.68
HUTCHMED (00013) 26.70 -7.45
GENSCRIPT BIO (01548) 8.78 -4.46
INNOVENT BIO (01801) 37.70 -4.92
WUXI BIO (02269) 10.72 -4.80
HENLIUS (02696) 22.80 -0.87
TIGERMED (03347) 26.95 -6.59
SKB BIO-B (06990) 145.70 -10.83
AKESO (09926) 36.80 -5.40
REMEGEN (09995) 17.42 -19.35
---------------------------------------------
(ed)